Karoly Toth

Karoly Toth is a notable inventor based in St. Louis, MO (US), recognized for his significant contributions to the field of antiviral research. With a total of 5 patents, Toth has developed innovative methods and tools aimed at combating viral infections and cancer.

Latest Patents

Among his latest patents is a screening tool for antiviral agents. This method involves reducing the activation of the immune system in small mammals, administering a human adenovirus vector, and monitoring tumor cells. The process includes analyzing infectious virus units within the tumor cells and organs of the small mammal, specifically using cyclophosphamide to suppress the immune system. Additionally, Toth has developed replication-competent anti-cancer vectors that are designed to target neoplastic cells. These vectors overexpress an adenovirus death protein and are restricted to neoplastic cells, providing a novel approach to promoting the death of cancerous cells.

Career Highlights

Karoly Toth is affiliated with Saint Louis University, where he continues to advance his research in antiviral and cancer therapies. His work has garnered attention for its potential impact on medical treatments and patient outcomes.

Collaborations

Toth collaborates with esteemed colleagues such as William S M Wold and Konstantin Doronin, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Karoly Toth's inventive spirit and dedication to research have led to significant advancements in the fields of virology and oncology. His contributions are paving the way for new therapeutic strategies that could benefit countless individuals in the future.

Profile summary based on public USPTO records.